The third Roundup trial to be held in Missouri–site of the former Monsanto Corp. headquarters–resulted in a defense verdict.
A judge denied a review of the Luke Vilsmeyer verdict, leaving the 13th bellwether trial stand but 3M will appeal.
Research studies show that babies born to women who took high doses of Tylenol (acetaminophen) while pregnant were 20% more likely to have autism.
With 30,000 unresolved Roundup cancer claims, plaintiff’s attorneys are pushing for another settlement or a remand of cases to district courts around the country.
A jury returned a defense verdict, marking Bayer’s 5th win at trial in a row, but the news is not all bad for plaintiffs.
A judge has appointed a settlement master while Bard faces tens of thousands of defective hernia mesh lawsuits.
3M’s subunit, Aearo Technologies, maker of CAEv2 military earplugs can still file for bankruptcy but that won’t stop 3M from facing 230,000 hearing damage lawsuits.
Scheduled for August 22, the first Zantac trial in the nation has been dismissed after the plaintiff reached an agreement with generic makers of the drug.
More than 2 years after yanking talc powder off U.S. shelves, J&J said it will do the same globally sometime next year.
Just days after 3M filed for Chapter 11 bankruptcy for its military earplug subunit, two veterans filed motions
3M is hoping that $1 billion and chapter 11 bankruptcy will resolve nearly 300,000 hearing damage claims. But will all plaintiffs agree to the trust fund?
An appeals court in Alabama has revived a Roundup weedkiller lawsuit that makes a Supreme Court review of previous decisions highly unlikely.
After mesothelioma-related asbesos lawsuits were paused because of Covid, an LA jury returned one of the largest verdicts in recent years.
A day after being issued marketing denial orders by the FDA, Juul filed for an emergency appeal, and that appeal is being reviewed by a federal court.
Despite winning its fourth straight Roundup trial, things aren’t all rosy for Bayer AG. The company faces a new mini class action among other setbacks.
The judge overseeing the multidistrict litigation 3M earplug trials has ordered both parties to begin mediation talks by July 15.
A jury in Kansas City cleared Bayer/Monsanto of liability in the sixth Roundup cancer trial–the first case to be tried outside of California.
A $55 million hearing damage award was reduced to $21 million because of caps set by Colorado law, which applies to the case of veteran William Wayman.
3M has been ordered to pay $300 million to 13 U.S. Army veterans in 10 earplug trials in the initial phase of the CAEv2 litigation.
Bayer was hoping the nation’s high court would review the third Roundup personal injury trial and wipe out the remaining 30,000 unresolved claims.
Hugh Grant, who led Monsanto for 15 years, was ordered by a judge to testify in a Roundup trial in person.
￼3M Military Earplug Trial #15 Results in $2 Million Plaintiff Verdict, Over $200 Million Awarded To Plaintiffs
3M’s trial record now stands at six wins and 9 losses in the first 15 military earplug trials. In 3M’s 9 losses, juries have awarded over $222 million to 12 plaintiffs.
Ethicon, a subunit of J&J, failed to warn women that its transvaginal/pelvic mesh surgical devices posed significant health risks.
J&J has temporarily escaped 40,000 consumer talc lawsuits through a controversial bankruptcy plan but it must face decades-old lawsuits from those allegedly harmed by talc in the workplace.
If you purchased Roundup weed killer products, you may be entitled to receive compensation for your purchases. But don’t forget that you can still sue the company for personal injury.
3M’s win-loss record in 14 earplug trials now stands at 6-8. A jury returned a defense verdict in the case of a veteran who is only the second female plaintiff whose case has been tried.
A new Roundup trial that was scheduled to start today was cancelled after a settlement was reached between Monsanto-owner, Bayer AG and dozens of plaintiffs.
The same judge who approved J&J’s plan to offload its talc liabilities into a bankrupt subunit has granted talc cancer plaintiffs a fast-track appeal in bankruptcy court.
Out of 13th bellwether CAEv2 trials, 3M has lost eight. Juries have returned over $200 million to 11 plaintiffs.
In the early 1970s, J&J funded research conducted human experiments in a prison that injected inmates with cancer-causing asbestos.
It is illegal for doctors to receive payments from pharmaceutical companies for prescribing their drugs yet roughly a quarter of over 800,000 doctors received opioid kickbacks during the height of the opioid crisis.
Members of the Sackler family, which created Oxycontin under Purdue Pharma must pay more money to resolve opioid litigation.
It’s still unclear how the approval of the bankruptcy would affect plaintiffs’ claims, however, critics believe it’s a miscarriage of justice.
3M appeals the first military earplug trial verdict and more developing news in the nation’s largest mass tort in history.
Bayer’s hoping that the nation’s high court will review one of the three Roundup decisions it has lost at trial, but it might be a Hail Mary at best.
Zantac maker, GSK, wants information from the independent pharmacy/lab that was the first to alert the FDA about cancer-causing NDMA in Zantac.
A group of the nation’s most respected law professors has filed an amicus brief, arguing that J&J’s bankruptcy plan to avoid paying asbestos-tainted talc victims sets a dangerous precedent.
3M has been hit with the largest verdict to date in the massive Combat Arms Earplug version 2 (CAEv2) multidistrict litigation.
Approximately 600 Elmiron eye damage lawsuits are consolidated in a New Jersey federal court. The latest addition to the MDL is a $10 million suit filed by a New Hampshire woman.